Conduct Clinical Trials during the COVID-19 Pandemic in India

Authors

  • Vishal Vennu School of Pharmacy, Lingaya’s Vidyapeeth, Faridabad, India and Department of Rehabilitation Sciences, College of Applied Medical Sciences, King Saud University, Riyadh, Saudi Arabia.

DOI:

https://doi.org/10.9734/bpi/mono/978-93-91882-02-0/CH6

Keywords:

COVID-19, pandemic, protocol, clinical trial, guidelines, India

Abstract

The major pandemics have been noted in the historical record and now Coronavirus Disease-2019 (COVID-19). The pathogen was first identified in late December 2019 in Wuhan, China, and the first case of COVID-19 was reported on 30 January 2020 in Kerala, India. At present, India has the second-highest number of confirmed cases in the world after the United States. In this situation, the COVID-19 pandemic crisis has impacted clinical research worldwide, especially in India. The chapter summarizes the conduct of clinical trials during the COVID-19 pandemic in India.

Published

2021-08-30

How to Cite

Vishal Vennu. (2021). Conduct Clinical Trials during the COVID-19 Pandemic in India. India’s New Drugs and Clinical Trial Rules: Perception and Perspectives of Indian Researchers, 30–32. https://doi.org/10.9734/bpi/mono/978-93-91882-02-0/CH6

Issue

India’s New Drugs and Clinical Trial Rules: Perception and Perspectives of Indian Researchers

Section

Contents